HKG Epitherapeutics – Pioneering Epigenetics
Professor Moshe Szyf, Founder and CEO of HKG Epitherapeutics, discusses epigenetic research, the company’s novel tools for early detection of cancer and promoting healthy aging, recent data published on the ability of the company’s proprietary epiCervix test to detect cervical cancer in patients sooner and more.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Moshe Szyf, PhD, Founder and CEO of HKG Epitherapeutics, a biotech company focusing on the development of cutting-edge early detection tools utilizing epigenetic technology and advanced next-generation sequencing to enhance cancer diagnosis, treatment, and patient outcomes.
Dr. Szyf is a geneticist and James McGill professor of pharmacology and therapeutics at the McGill University, where he also holds a GlaxoSmithKline-CIHR chair in pharmacology.
He is widely recognized for his groundbreaking research spanning over three decades, which has revolutionized the fields of genetics and early cancer detection. Notably, he presented the first compelling evidence that challenges the long-held notion of fixed genetic makeup at birth. Dr. Szyf’s profound insights reveal that our genetic code can be dynamically altered through a biochemical process known as “DNA methylation.”
Szyf received his Ph. D from the Hebrew University and did his postdoctoral fellowship in Genetics at Harvard Medical School.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
